COLES N ANTHONY

CIK 000119701810 companiesTARRYTOWN, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001197018

Recent Transactions

50 trades

Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2026-01-02+155→ 1,714 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2026-01-02+1,962→ 1,962 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-01-02+1,958→ 1,958 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-01-02+166→ 1,559 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−4,809,418→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−15,638→ 10,290 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−10,290→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-08-01−46,322→ 0 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-07-01$3.50/sh+25,000→ 50,928 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-07-01−25,000→ 2,177,417 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-07-01$41.18/sh−25,000→ 25,928 total
Award
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-06-05+10,290→ 25,928 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-06-03−50,000→ 2,202,417 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-06-03$40.61/sh−50,000→ 15,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-06-03$3.50/sh+50,000→ 65,638 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-05-10$42.10/sh−50,000→ 15,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-05-10−50,000→ 2,252,417 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-05-10$3.50/sh+50,000→ 65,638 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-04-01$42.33/sh−50,000→ 15,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-04-01−50,000→ 2,302,417 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-04-01$3.50/sh+50,000→ 65,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-03-04$3.50/sh+50,000→ 65,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-03-04−50,000→ 2,352,417 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-03-04$41.01/sh−50,000→ 15,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-02-29−50,000→ 2,402,417 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-02-29$3.50/sh+50,000→ 65,638 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-02-29$41.16/sh−50,000→ 15,638 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-02-07$41.54/sh−2,506→ 15,638 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Restricted Stock Units
2024-02-06−15,440→ 46,322 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-02-06+15,440→ 18,144 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-01-02$42.24/sh−50,000→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-01-02−50,000→ 2,452,417 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02+135→ 1,393 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-01-02+1,607→ 1,607 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-01-02$3.50/sh+50,000→ 52,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-14$3.50/sh+22,824→ 25,528 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-11-14−22,824→ 2,502,417 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-14$25.13/sh−22,824→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-11-08−100→ 2,525,241 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-08$25.16/sh−100→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-08$3.50/sh+100→ 2,804 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-07$25.02/sh−27,076→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-11-07−27,076→ 2,525,341 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-07$3.50/sh+27,076→ 29,780 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-03$3.50/sh+61,401→ 64,105 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-03$25.43/sh−61,401→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-11-03−61,401→ 2,552,417 total
Sale
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-02$25.19/sh−38,599→ 2,704 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-11-02$3.50/sh+38,599→ 41,303 total
Exercise/Conversion
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-11-02−38,599→ 2,613,818 total

Companies

Recent Filings

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591

View on SEC.gov